XML 52 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Shareholders' Equity
 12 Months Ended
Dec. 30, 2022
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders’ EquityAt December 30, 2022, the Company had 22,549 authorized, but not issued, cumulative preferred shares, $100 par value. The Company also has authorized, but not issued, a separate class of 3 million shares of preferred stock, $1 par value.
Changes in components of accumulated other comprehensive income (loss), net of tax were (in thousands):
Pension and
Postretirement
Medical		Cumulative
Translation
Adjustment		Total
Balance, December 27, 2019$(113,721)$(56,066)$(169,787)
Other comprehensive income (loss) before reclassifications(7,852)46,030 38,178 
Amounts reclassified from accumulated other comprehensive income7,444 — 7,444 
Balance, December 25, 2020(114,129)(10,036)(124,165)
Other comprehensive income (loss) before reclassifications34,953 (10,026)24,927 
Amounts reclassified from accumulated other comprehensive income19,069 — 19,069 
Balance, December 31, 2021(60,107)(20,062)(80,169)
Other comprehensive income (loss) before reclassifications16,083 (9,582)6,501 
Amounts reclassified from accumulated other comprehensive income4,290 — 4,290 
Balance, December 30, 2022$(39,734)$(29,644)$(69,378)

In connection with the Company's sale of its U.K.-based valve business in 2020, $24 million of unrealized foreign currency translation losses recorded in accumulated other comprehensive income were reclassified to net earnings.
Amounts related to pension and postretirement medical adjustments are classified to non-service components of pension cost that are included within other non-operating expenses. Included in the 2021 reclassification is $12 million related to a pension settlement loss. See Note J for additional details regarding pension and postretirement medical plans.